These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3072929)

  • 1. [Various principles of detecting the producers of beta-lactamase inhibitors among soil Actinomycetes].
    Kuznetsova OS; Alenicheva NB; Ovchinnikova AG; Levit ZhD; Kuz'mina ED
    Antibiot Khimioter; 1988 Dec; 33(12):895-900. PubMed ID: 3072929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various methodological approaches in controlled screening of antibiotic producers among the group of Coryneform bacteria].
    Obgol'tseva IO; Kuznetsova OS; Iakovleva EP
    Antibiot Khimioter; 1991 Aug; 36(8):6-10. PubMed ID: 1755714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Procop GW; Tuohy MJ; Wilson DA; Williams D; Hadziyannis E; Hall GS
    Am J Clin Pathol; 2003 Aug; 120(2):265-7. PubMed ID: 12931557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly targeted screening system for carbapenem antibiotics.
    Nakamura Y; Ono E; Kohda T; Shibai H
    J Antibiot (Tokyo); 1989 Jan; 42(1):73-83. PubMed ID: 2784131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indicator method of determining the beta-lactamase-inhibiting activity of various compounds].
    Ivanitskaia LP; Nikishina VG
    Antibiotiki; 1981 Apr; 26(4):259-64. PubMed ID: 6972191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M; Pous-Miralles G; Romera-Sastre G; Panisello-Bertomeu JM; Jardí-Baiges AM; Zarazoga-López J
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):477-81. PubMed ID: 9527373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of plasmid-mediated AmpC β-lactamase in Escherichia coli and Klebsiella pneumoniae.
    Yilmaz NO; Agus N; Bozcal E; Oner O; Uzel A
    Indian J Med Microbiol; 2013; 31(1):53-9. PubMed ID: 23508430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
    Wienke M; Pfeifer Y; Weissgerber P; Marschal M; Autenrieth IB; Gröbner S
    Chemotherapy; 2012; 58(3):241-8. PubMed ID: 22832033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Apisarnthanarak A; Kiratisin P; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):671-4. PubMed ID: 18624669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715.
    Farmer TH; Page JW; Payne DJ; Knowles DJ
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):825-30. PubMed ID: 7980451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.